{"id":4496,"date":"2026-10-30T17:32:02","date_gmt":"2026-10-30T14:32:02","guid":{"rendered":"https:\/\/www.sonerduzguner.com\/?p=4496"},"modified":"2026-10-30T17:32:02","modified_gmt":"2026-10-30T14:32:02","slug":"embriyo-yapistirici-embryoglue-nedir","status":"publish","type":"post","link":"https:\/\/www.sonerduzguner.com\/en\/embriyo-yapistirici-embryoglue-nedir\/","title":{"rendered":"Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 (EmbryoGlue) Nedir? T\u00fcp Bebekte Ne \u0130\u015fe Yarar?"},"content":{"rendered":"
\n\t
\n\t\t
\n\t\t\t

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131, t\u00fcp bebek tedavisinde embriyo transferi s\u0131ras\u0131nda kullan\u0131lan, hyal\u00fcronan olarak da adland\u0131r\u0131lan hyal\u00fcronik asit bak\u0131m\u0131ndan zenginle\u015ftirilmi\u015f \u00f6zel bir transfer ortam\u0131d\u0131r. EmbryoGlue ad\u0131yla bilinen (yabanc\u0131 kaynaklarda \u201cembryo glue\u201d olarak da ge\u00e7en) bu uygulama, embriyonun rahim i\u00e7 zar\u0131na tutunma s\u00fcrecini desteklemek amac\u0131yla de\u011ferlendirilen ek y\u00f6ntemlerden biridir. Bu nedenle t\u00fcp bebekte embriyo yap\u0131\u015ft\u0131r\u0131c\u0131, \u201chyal\u00fcronik asitli embriyo transferi\u201d olarak da ifade edilir.<\/p>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131, ad\u0131n\u0131n d\u00fc\u015f\u00fcnd\u00fcrd\u00fc\u011f\u00fc gibi embriyoyu rahme mekanik olarak yap\u0131\u015ft\u0131rmaz ve gebelik garantisi sa\u011flamaz. Baz\u0131 ara\u015ft\u0131rmalarda olumlu sonu\u00e7lar bildirilse de her hastada ayn\u0131 yarar\u0131n ortaya \u00e7\u0131kaca\u011f\u0131 s\u00f6ylenemez. Kullan\u0131m karar\u0131, \u00e7iftin tedavi ge\u00e7mi\u015fi ve mevcut transfer plan\u0131 birlikte de\u011ferlendirilerek verilmelidir.<\/p>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 Nas\u0131l Etki Eder?<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n i\u00e7eri\u011findeki hyal\u00fcronik asit, insan v\u00fccudunda ve kad\u0131n \u00fcreme sisteminde do\u011fal olarak bulunan bir maddedir. H\u00fccreler aras\u0131ndaki etkile\u015fimde rol oynar ve bulundu\u011fu ortam\u0131n k\u0131vam\u0131n\u0131 etkiler.<\/p>\n\n

Transfer ortam\u0131ndaki hyal\u00fcronik asit miktar\u0131n\u0131n art\u0131r\u0131lmas\u0131yla, embriyonun rahim i\u00e7 zar\u0131yla etkile\u015fiminin desteklenmesi ama\u00e7lan\u0131r. Ancak embriyo tutunmas\u0131; embriyonun \u00f6zellikleri, rahim i\u00e7i ko\u015fullar ve transfer zamanlamas\u0131 gibi bir\u00e7ok etkenin birlikte rol ald\u0131\u011f\u0131 biyolojik bir s\u00fcre\u00e7tir. Tek bir destek uygulamas\u0131 bu s\u00fcrecin tamam\u0131n\u0131 belirlemez.<\/p>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 Nas\u0131l Uygulan\u0131r?<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131, laboratuvarda transfer haz\u0131rl\u0131\u011f\u0131n\u0131n bir par\u00e7as\u0131 olarak kullan\u0131l\u0131r. Embriyo, transfer \u00f6ncesinde hyal\u00fcronik asitten zengin ortamda belirli bir s\u00fcre bekletilir ve uygun transfer ortam\u0131yla rahim i\u00e7ine yerle\u015ftirilir.<\/p>\n\n

Hasta a\u00e7\u0131s\u0131ndan ayr\u0131ca bir ameliyat veya rahim duvar\u0131na yap\u0131\u015ft\u0131r\u0131c\u0131 s\u00fcr\u00fclmesi s\u00f6z konusu de\u011fildir. Uygulama, embriyoloji laboratuvar\u0131 ile t\u00fcp bebek hekiminin birlikte planlad\u0131\u011f\u0131 transfer s\u00fcrecine d\u00e2hildir.<\/p>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 \u0130\u015fe Yarar m\u0131? Gebelik \u015eans\u0131n\u0131 Art\u0131r\u0131r m\u0131?<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n gebelik ve canl\u0131 do\u011fum olas\u0131l\u0131\u011f\u0131na katk\u0131 sa\u011flayabilece\u011fini g\u00f6steren \u00e7al\u0131\u015fmalar vard\u0131r. Bununla birlikte ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131 tamamen ayn\u0131 de\u011fildir; gebelik elde edilmesi ile canl\u0131 do\u011fumla sonu\u00e7lanmas\u0131 da ayr\u0131 de\u011ferlendirilmelidir.<\/p>\n\n

2020 tarihli Cochrane derlemesinde, hyal\u00fcronik asitten zengin transfer ortamlar\u0131n\u0131n klinik gebelik ve canl\u0131 do\u011fum oranlar\u0131n\u0131 muhtemelen art\u0131rd\u0131\u011f\u0131 bildirilmi\u015ftir. Buna kar\u015f\u0131l\u0131k \u0130ngiltere\u2019nin \u00fcreme tedavilerini d\u00fczenleyen kurumu HFEA, \u00e7al\u0131\u015fmalar aras\u0131ndaki farkl\u0131l\u0131klar nedeniyle \u00e7o\u011fu hasta i\u00e7in yarar\u0131n kesinle\u015fmedi\u011fini belirtmektedir. Bu nedenle embriyo yap\u0131\u015ft\u0131r\u0131c\u0131 ba\u015far\u0131 oran\u0131 i\u00e7in herkese ge\u00e7erli tek bir ba\u015far\u0131 art\u0131\u015f\u0131 y\u00fczdesi vermek do\u011fru olmaz. T\u00fcp bebek ba\u015far\u0131 oran\u0131<\/a>; kad\u0131n\u0131n ya\u015f\u0131, embriyo kalitesi ve rahim i\u00e7 zar\u0131n\u0131n durumu gibi etkenlere g\u00f6re ki\u015fiden ki\u015fiye de\u011fi\u015fir.<\/p>\n\n

<\/span>Tekrarlayan Embriyo Tutunma Ba\u015far\u0131s\u0131zl\u0131\u011f\u0131nda Kullan\u0131l\u0131r m\u0131?<\/span><\/h2>\n\n

Tekrarlayan embriyo tutunma ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 ya\u015fayan \u00e7iftlerde, \u00f6nceki tedavilerin ayr\u0131nt\u0131lar\u0131 dikkate al\u0131narak ek destek se\u00e7enekleri de\u011ferlendirilebilir. Tekrarlayan t\u00fcp bebek ba\u015far\u0131s\u0131zl\u0131\u011f\u0131n\u0131n nedenleri aras\u0131nda embriyo, rahim ve ba\u011f\u0131\u015f\u0131kl\u0131kla ilgili farkl\u0131 etkenler bulunabilece\u011finden, \u00f6nce bu nedenlerin ara\u015ft\u0131r\u0131lmas\u0131 \u00f6nemlidir. Ancak bu \u00f6yk\u00fcn\u00fcn bulunmas\u0131, embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n mutlaka yarar sa\u011flayaca\u011f\u0131 anlam\u0131na gelmez.<\/p>\n\n

Klini\u011fimizde tedaviyi en ba\u015f\u0131ndan ki\u015fiye \u00f6zel planl\u0131yoruz. Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131y\u0131 da \u00f6zellikle tekrarlayan tutunma ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 \u00f6yk\u00fcs\u00fc olan baz\u0131 olgularda ek destek olarak tercih edebiliyoruz. Soner Bey\u2019in klinik deneyiminde uygun g\u00f6r\u00fclen olgularda yararl\u0131 olabildi\u011fi g\u00f6zlemlense de bu g\u00f6zlem, t\u00fcm hastalar i\u00e7in ayn\u0131 sonucun al\u0131naca\u011f\u0131n\u0131 g\u00f6stermez.<\/p>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 \u0130kiz Gebelik Riskini Art\u0131r\u0131r m\u0131?<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131yla ilgili baz\u0131 ara\u015ft\u0131rmalarda \u00e7o\u011ful gebelik oranlar\u0131nda art\u0131\u015f bildirilmi\u015ftir. Bu bulgu, \u00f6zellikle birden fazla embriyo transfer edildi\u011finde tutunan embriyo say\u0131s\u0131n\u0131n artmas\u0131yla ili\u015fkili olabilir.<\/p>\n\n

Bu sonu\u00e7, embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n tek bir embriyoyu b\u00f6lerek ikiz olu\u015fturdu\u011funun kan\u0131t\u0131 de\u011fildir. \u00c7o\u011ful gebelik de\u011ferlendirmesinde transfer edilen embriyo say\u0131s\u0131 \u00f6nemlidir. Bu nedenle uygulama karar\u0131 ile ka\u00e7 embriyo transfer edilece\u011fi birlikte ele al\u0131nmal\u0131d\u0131r. Ara\u015ft\u0131rmalarda embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n yan etkileri aras\u0131nda \u00f6ne \u00e7\u0131kan ba\u015fl\u0131ca konu da bu \u00e7o\u011ful gebelik art\u0131\u015f\u0131d\u0131r.<\/p>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 Her Hastada Gerekli mi? Kimlere Uygulan\u0131r?<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131, t\u00fcp bebek tedavisinin her hastada uygulanmas\u0131 zorunlu bir basama\u011f\u0131 de\u011fildir. Kullan\u0131lmamas\u0131 tedavinin eksik yap\u0131ld\u0131\u011f\u0131 anlam\u0131na gelmez; kullan\u0131lmas\u0131 da ba\u015far\u0131s\u0131zl\u0131k ihtimalini ortadan kald\u0131rmaz. Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131n\u0131n kimlere uygulanaca\u011f\u0131 ve ne zaman kullan\u0131laca\u011f\u0131, hastan\u0131n tedavi ge\u00e7mi\u015fine g\u00f6re hekim taraf\u0131ndan belirlenir.<\/p>\n\n

Karar verirken \u015fu konular\u0131n a\u00e7\u0131kl\u0131\u011fa kavu\u015fmas\u0131 yararl\u0131d\u0131r:<\/p>\n\n\n\n\n\n\n\n\n\n\n
De\u011ferlendirilen konu<\/th>\nHastan\u0131n sorabilece\u011fi soru<\/th>\n<\/tr>\n<\/thead>\n
Kullan\u0131m gerek\u00e7esi<\/td>\nBenim tedavimde neden \u00f6neriliyor?<\/td>\n<\/tr>\n
Beklenen katk\u0131<\/td>\nBenim durumuma benzer hastalarda yarar\u0131na ili\u015fkin kan\u0131t var m\u0131?<\/td>\n<\/tr>\n
Transfer plan\u0131<\/td>\nKa\u00e7 embriyo transfer edilecek?<\/td>\n<\/tr>\n
Belirsizlikler<\/td>\nOlas\u0131 yararlar\u0131 ve s\u0131n\u0131rl\u0131l\u0131klar\u0131 neler?<\/td>\n<\/tr>\n
Maliyet<\/td>\nEk bir \u00fccreti var m\u0131, SGK kapsam\u0131nda m\u0131?<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n

<\/span>Embriyo Yap\u0131\u015ft\u0131r\u0131c\u0131 Fiyat\u0131 ve SGK<\/span><\/h2>\n\n

Embriyo yap\u0131\u015ft\u0131r\u0131c\u0131 fiyat\u0131, klini\u011fe ve tedavi plan\u0131na g\u00f6re farkl\u0131l\u0131k g\u00f6sterebilir. SGK\u2019n\u0131n bu uygulamay\u0131 kar\u015f\u0131lay\u0131p kar\u015f\u0131lamad\u0131\u011f\u0131, g\u00fcncel geri \u00f6deme ko\u015fullar\u0131na ve tedavinin kapsam\u0131na ba\u011fl\u0131d\u0131r. Bu nedenle \u00fccret ve SGK kapsam\u0131 konusunda tedavi \u00f6ncesinde klini\u011finizden bilgi alman\u0131z en do\u011frusudur.<\/p>\n\n

<\/span>Embriyo Transferi Sonras\u0131 Tutunma \u0130\u00e7in Ne Yapmal\u0131?<\/span><\/h2>\n\n

Embriyonun rahme tutunmas\u0131 i\u00e7in yap\u0131labilecekler, b\u00fcy\u00fck \u00f6l\u00e7\u00fcde hekimin \u00f6nerilerine uymakla ilgilidir: \u00d6nerilen ila\u00e7lar\u0131n d\u00fczenli kullan\u0131lmas\u0131, dengeli beslenme ve stresten olabildi\u011fince uzak durulmas\u0131 bu s\u00fcrece destek olur. Embriyo transferi<\/a> sonras\u0131 tutunma belirtileri ki\u015fiden ki\u015fiye de\u011fi\u015fir ve gebeli\u011fi g\u00fcvenilir bi\u00e7imde g\u00f6stermez. Sonucu \u00f6\u011frenmenin en do\u011fru yolu, hekimin belirtti\u011fi g\u00fcnde yap\u0131lan kan gebelik testidir.<\/p>\n\n

Klini\u011fimizde yakla\u015f\u0131m\u0131m\u0131z, embriyo yap\u0131\u015ft\u0131r\u0131c\u0131y\u0131 bir mucize olarak sunmadan, uygun g\u00f6r\u00fclen hastalarda tedavi plan\u0131n\u0131n bir par\u00e7as\u0131 olarak de\u011ferlendirmektir. Hedefimiz yaln\u0131zca gebelik elde etmek de\u011fil, sa\u011fl\u0131kl\u0131 bir gebelik ve do\u011fuma ula\u015fmakt\u0131r.<\/p>\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
\n\t
\n\t\t
\n\t\t\t
Let Us Call You<\/span><\/div>\n\n\t\t<\/div>\n\t<\/div>
\n\t\n\t\t<\/span>\n\t<\/span>\n<\/div>\n\t
\n\t\t
\n\t\t\t

Let us reach you quickly about the topics you want to consult.<\/span><\/p>\n\n\t\t<\/div>\n\t<\/div>

\n\t\n\t\t<\/span>\n\t<\/span>\n<\/div>\n
\n

<\/p>